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a  b  s  t  r  a  c  t
Importance  of  the  dry period  with  respect  to mastitis  control  is  now  well  established  although  the  pre-
cise  interventions  that reduce the risk  of acquiring  intramammary  infections  during  this  time  are  not
clearly  understood.  There  are  very  few  intervention  studies  that  have  measured  the clinical  efﬁcacy  of
speciﬁc  mastitis  interventions  within  a  cost-effectiveness  framework  so  there  remains  a large  degree  of
uncertainty  about  the  impact  of  a speciﬁc  intervention  and  its costeffectiveness.  The aim  of this  study
was  to  use  a Bayesian  framework  to investigate  the cost-effectiveness  of mastitis  controls  during  the
dry  period.  Data  were  assimilated  from  77  UK  dairy  farms  that  participated  in a British  national  mastitis
control  programme  during  2009–2012  in which  the majority  of intramammary  infections  were  acquired
during  the  dry period.  The  data  consisted  of clinical  mastitis  (CM)  and somatic  cell  count (SCC)  records,
herd  management  practices  and  details  of  interventions  that  were  implemented  by the  farmer  as  part  of
the control  plan.  The  outcomes  used  to  measure  the  effectiveness  of  the  interventions  were  i) changes
in  the  incidence  rate  of clinical  mastitis  during  the  ﬁrst  30 days  after  calving  and  ii) the rate  at  which
cows  gained  new  infections  during  the  dry  period  (measured  by  SCC  changes  across  the  dry  period  from
<200,000  cells/ml  to  >200,000  cells/ml).  A  Bayesian  one-step  microsimulation  model  was  constructed
such  that  posterior  predictions  from  the model  incorporated  uncertainty  in  all  parameters.  The  incre-
mental  net  beneﬁt  was  calculated  across  10,000  Markov  chain  Monte  Carlo  iterations,  to  estimate  the
cost-beneﬁt  (and  associated  uncertainty)  of  each  mastitis  intervention.  Interventions  identiﬁed  as  being
cost-effective  in  most  circumstances  included  selecting  dry-cow  therapy  at the  cow  level,  dry-cow  rations
formulated by a qualiﬁed  nutritionist,  use  of  individual  calving  pens, ﬁrst milking  cows  within  24 h of
calving  and  spreading  bedding  evenly  in dry-cow  yards.  The  results  of this  study  highlighted  the  efﬁcacy
of speciﬁc  mastitis  interventions  in UK  conditions  which,  when  incorporated  into  a costeffectiveness
framework,  can  be used  to optimize  decision  making  in  mastitis  control.  This  intervention  study  pro-
vides  an  example  of how  an  intuitive  and  clinically  useful  Bayesian  approach  can  be used  to form  the
basis  of an  on-farm  decision  support  tool.
© 2016  Published  by  Elsevier  B.V.
1. Introduction
Mastitis remains one of the most costly endemic diseases to the
dairy industry worldwide in terms of production, animal welfare
and potential risks to public health (Bradley, 2002; Hagnestam-
Nielsen and Ostergaard, 2009; Halasa, 2012). The importance of the
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dry period with respect to mastitis control is now well established
(Bradley and Green, 2000, 2004; Green et al., 2002; Bradley et al.,
2015) however the precise interventions that reduce the risk of
acquiring intramammary infections (IMI) during this time are not
clearly understood.
There exists a vast body of literature reporting associations
between various management practices and different measures of
udder health e.g. Dufour et al. (2011). A potential limitation with
risk factor studies is that they cannot always provide evidence of
causation and so there remains a large degree of uncertainty as
http://dx.doi.org/10.1016/j.prevetmed.2016.09.012
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to the likely impact that a speciﬁc intervention has and therefore
its overall cost-effectiveness. Intervention studies can provide evi-
dence of causation (Rubin, 2007; Martin, 2013), but there are very
few intervention studies that have sought to measure the efﬁcacy of
speciﬁc mastitis control interventions within a cost-effectiveness
framework (Green et al., 2010). Furthermore, uncertainty about
the clinical and ﬁnancial beneﬁt of an intervention, will affect the
decision to implement it (Green et al., 2010; Huijps et al., 2010).
If potential interventions are to be prioritised in a rational and
evidence-based way, cost-beneﬁt analyses are required that cap-
ture the uncertainty of the efﬁcacy of interventions.
With limited resources available to a commercial dairy farm,
it is important that potential mastitis interventions are prioritised
not only according to their efﬁcacy, but also on the likely return
on investment. The efﬁcient use of available resources requires
an understanding of the opportunity costs whereby resources are
allocated to fund one intervention at the expense of the potential
‘beneﬁts’ afforded by an alternative intervention. It is necessary
when deciding whether to employ resources in one area to be able
to compare the probability of a net beneﬁt in that area with all
other potential areas where those resources could be employed
(Briggs and Gray, 1999). This is the dilemma faced by veterinary
decision makers, and with many possible mastitis interventions
making claims on farm resources, this decision is rarely intuitive.
Bayesian methods are now widely adopted by the human medi-
cal ﬁeld for the analysis of cost-effectiveness (Briggs, 2001; Claxton
et al., 2002; O’Hagan and Stevens, 2002; Spiegelhalter and Best,
2003; Claxton, 2008). A key feature of such cost-effectiveness
studies is that Bayesian analysis of decision making under uncer-
tainty requires model parameters to be speciﬁed as probability
distributions (Felli and Hazen, 1999). The probability distributions
represent the degree of uncertainty surrounding the true values of
model parameters, which is then propagated through the model
(O’Hagan, 2003). This approach makes it possible to make genuine
probability statements about the magnitude of such parameters
and attach a probability to a speciﬁc hypothesis of interest (Gurrin
et al., 2000). One method termed comprehensive decision mod-
elling, integrates evidence synthesis and parameter estimation
with probabilistic decision analysis in a single uniﬁed framework
(Cooper et al., 2004; Spiegelhalter et al., 2004; Ades et al., 2006).
The resulting posterior probability distribution provides a realis-
tic probabilistic interpretation from which statements about the
probability of a hypothesis can be made.
The aim of this study was to investigate the cost-effectiveness
of mastitis control interventions to reduce IMI  caused by environ-
mental pathogens (opportunistic invaders from an environmental
reservoir) during the dry period. An integrated Bayesian cost-
effectiveness framework was used to construct a probabilistic
decision model that could be used to inform clinical decision mak-
ing.
2. Materials and methods
2.1. Background to the AHDB Dairy Mastitis Control Plan (DMCP)
The DMCP (Green et al., 2007a) was delivered by local veterinary
practitioners and dairy farm consultants throughout the UK who
received training by the plan support team consisting of specialist
dairy veterinarians. When each dairy farm was enrolled onto the
DMCP, a copy of their herd health and performance data, includ-
ing clinical mastitis (CM) incidence and somatic cell count (SCC)
records, was submitted to the DMCP support team for analysis. The
farm was subsequently visited by the plan deliverer who completed
a questionnaire consisting of 377 questions covering all aspects of
management relevant to mastitis control and also included obser-
vations and measurements to be collected during the visit. Each
of the 377 questions/observations was  associated with a corre-
sponding intervention e.g. Question: How often are straw yards
completely cleaned out? Intervention: Straw yards must be com-
pletely mucked out, at least, every 4 weeks. The answers to this
questionnaire were recorded in a bespoke software programme
called the ‘ePlan’ (‘SUM-IT Computer Systems Ltd,’ 2009). The DMCP
support team analysed the clinical and subclinical mastitis data
submitted by the plan deliverer with the aim of identifying the
primary herd infection pattern i.e. predominantly environmental
or contagious, and whether IMI’s were likely to be predominantly
acquired during the dry period or lactating period, as described pre-
viously (Bradley et al., 2008). Each herd was  assigned one of four
‘diagnoses’; environmental dry period (EDP), environmental lacta-
tion (EL), contagious dry period (CDP) or contagious lactation (CL)
and this was recorded in the ePlan software. Once all of the ePlan
questions and herd ‘diagnosis’ had been completed, the ePlan soft-
ware was used to highlight areas of suboptimal management most
relevant to the ‘diagnosis’ (Green et al., 2007a). The plan deliverer
‘prioritised’ 5–10 of these highlighted interventions for discussion
with the farmer and sought agreement on which of them to imple-
ment. The mastitis performance was  monitored on a regular basis
thereafter by evaluating both clinical and subclinical mastitis data
and a full analysis completed after a 12 month period.
2.2. Data collection
There were 265 plan deliverers at the time of the study and
each was  asked to submit their ePlan data, which consisted of
the answers to the questionnaire, the interventions prioritised and
the herd ‘diagnosis’ for each of the farms they had visited. They
were also asked to submit the herd health and performance data
recorded on-farm, consisting of CM and SCC records, herd size
and milk production data, covering the 12 months prior to the
DMCP start date and the ﬁrst 12 months from after the plan was
implemented. Out of the 265 plan deliverers, 87 plan deliverers
responded. From the 87 plan deliverers that responded, ePlan data
were received for a total of 452 herds that had participated in the
DMCP during 2009–2012. Complete herd health and performance
data were available for 290 of the 452 herds submitted. The 87 plan
deliverers that had responded were asked to specify the interven-
tions that were actually implemented on-farm over the 12 months
after the initial herd visit. The plan deliverers submitted this infor-
mation for 212 out of the 290 herds for which complete data were
available. From the 212 herds with complete data, 77 herds were
assigned an ‘EDP’ diagnosis and therefore used in this study. All
of this information was collated in a Microsoft Access database
(Microsoft Corp., Redmond, WA).
2.3. Data analysis
The clinical and subclinical mastitis data for each of the 77 herds
were initially checked for completeness and any herds with incom-
plete records were excluded from the analysis; 73 herds out of the
77 had complete SCC data and were used for the SCC analysis and
64 herds out of the 77 had complete CM data and were therefore
used for the CM analysis. In total, data from all 77 herds was used as
each of those herds had at least one of complete SCC and CM data.
The outcome of interest in this research was mastitis originating
from infections acquired during the dry period as reﬂected by clin-
ical mastitis and somatic cell count records. Therefore to measure
this, the incidence rate of clinical mastitis during the ﬁrst 30 days
after calving (IRCM30) was used (reported by DMCP participants
as the number of cases/12 cows/month) which has been shown
to be correlated to intramammary infections acquired during the
dry period (Bradley and Green, 2000; Green et al., 2002), and the
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Fig. 1. Overview of the 1-step micro-simulation procedure using the clinical mas-
titis micro-simulation model as an example. IRCM30 = incidence rate of clinical
mastitis in the ﬁrst 30 days after calving.
monthly percentage of cows that had a SCC <200,000 cells/ml at
the milk recording prior to drying off, that were >200,000 cells/ml
at the ﬁrst milk recording after parturition (HighSCC), which has
also been shown to be indicative of new dry period intramammary
infections (Bradley et al., 2002; Cook et al., 2002; Bradley and Green,
2005).
Interventions that had been implemented on at least two
farms were identiﬁed and for each farm, categorised as 0 (not
already implemented at the time of the initial farm visit and
not implemented following the intervention visit), 1 (not already
implemented at the time of the initial farm visit but implemented
following the DMCP) or 2 (already implemented at the time of the
initial farm visit or not applicable). Interventions were classiﬁed as
not applicable when they concerned an area of management not
relevant to a particular farm (e.g. management of dry cow cubicles
on a farm that used straw yards to house the dry cows). Collinearity
between covariates was assessed using Pearson product-moment
correlation coefﬁcients, and no substantial collinearity was found
(all correlation coefﬁcients were <0.7).
A Bayesian one-step micro-simulation model was  constructed
in OpenBUGS version 3.2.2 (Lunn et al., 2009) separately for each of
the two outcomes, incorporating a multiple regression model and
an onwards cost-effectiveness micro-simulation, based on meth-
ods described previously (Spiegelhalter et al., 2004). Therefore, the
posterior distributions from the one-step micro-simulation model
incorporated uncertainty in all model parameters (Fig. 1.).
The regression models that were incorporated in the ﬁrst stage
of the micro-simulation models took the form;
Yi = ˇ0 + ˇ1x1i + ˇ2x2i + ˇ3x3i + . . . + ˇpxpi + εii = 1, . . ., n εi∼N(0, 2ε ) (1)
where Yi = the ith observation of the outcome variable,
ˇ0 = intercept value, xpi = the pth predictor variable for the ith
herd, ˇp = the pth regression coefﬁcient, εi = the residual error,
p = number of predictor variables and n = the number of herds.
The outcome variable (Yi) used for the clinical mastitis regres-
sion model was  the percentage change in the IRCM30 during the 12
month period from implementation of the recommended interven-
tions and the outcome variable (Yi) used in the somatic cell count
regression model was the percentage change in the HighSCC rate
during this 12 month period. Both of these variables were approx-
imately normally distributed as determined using Q–Q plots. The
inﬂuence of any outlying residuals was  assessed using the Cook’s D
value.
Clinical mastitis regression model outcome
= IRCM30 (12 months) − IRCM30 (initial)
IRCM30 (initial)
× 100
where IRCM30(12 months) = the mean IRCM30 during the
ﬁrst 12 months after the mastitis control plan started and
IRCM30(initial) = the mean IRCM30 during the 12 months before
the mastitis control plan started.
Somatic cell count regression model outcome
= HighSCC (12 months) − HighSCC (initial)
HighSCC (initial)
× 100
where HighSCC(12 months) = the mean HighSCC during the
ﬁrst 12 months after the mastitis control plan started and High-
SCC(initial) = the mean HighSCC during the 12 months before the
mastitis control plan started.
Vague prior distributions were used for model parameters
as follows; 2 ∼ Gamma(0.001,0.001), and  ∼ Normal(0,106). The
predicted values from the model for the outcome variables for each
herd were compared with the observed data and displayed graphi-
cally to illustrate model performance. Full probability distributions
of the intervention efﬁcacy estimates from the regression models
were carried forward into the next stages of the micro-simulation
model.
The purpose of the micro-simulation was to simulate the cost-
effectiveness of each intervention in theoretical herds with a herd
size of 120 cows, with different initial rates of IRCM30 and HighSCC
and different costs associated with implementing each interven-
tion (Fig. 1). The values for IRCM30 and HighSCC on the simulated
farms prior to interventions being implemented were taken from
actual data from 125 herds that had previously participated in the
DMCP so that a range of plausible scenarios were used. The micro-
simulation comprised the steps described below; each step was
undertaken at each model iteration.
Step 1. The regression model (1) was  used to obtain an estimate
of the percentage change in the IRCM30 after a 12 month period
for each intervention for a given herd. The initial IRCM30 increased
or decreased according to the estimated percentage change and
this resulted in a predicted new IRCM30 for each farm once it had
implemented the intervention (IRCM30PRED).
Step 2. The resulting increase/decrease in the number of cases
during a 12 month period (CASESCMPREV) in a 120-cow herd was
then simulated for each intervention individually by multiplying
the difference between the initial IRCM30 (IRCM30INITIAL) and the
predicted IRCM30 (IRCM30PRED) by 10 to convert the denominator
from the number of cases per 12 cows, to the number of cases per
120 cows:
CASESCMPREV = (IRCM30INITIAL − IRCM30PRED) × 10
Step 3. The change in annual cost of clinical mastitis for a 120
cow herd (SAVINGCM) was calculated at each iteration by multiply-
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Fig. 2. Probabilistic cost-effectiveness curves for speciﬁc interventions. IRCM30 = the incidence rate of clinical mastitis in the ﬁrst 30 days after calving. HighSCC = monthly
percentage of cows that had a somatic cell count <200,000 cells/ml at the milk recording prior to drying off, that were >200,000 cells/ml at the ﬁrst milk recording after
parturition.
ing the number of cases prevented (CASESCMPREV) by the cost of a
case of clinical mastitis (COSTCM):
SAVINGCM = CASESCM × COSTCM
A cost per case of clinical mastitis within 30 days of calving
was speciﬁed as a full probability distribution, COSTCM ∼ Normal
(mean = 313, sd = 101), based on a stochastic simulation study in
the UK (Green et al., 2009). A cost was selected at random from this
distribution at each iteration and multiplied by the number of cases
prevented to give an overall saving in pounds sterling associated
with the implementation of each intervention.
Step 4. The incremental net beneﬁt (INB) was calculated at each
iteration to represent the overall net beneﬁt after all ‘savings’ and
‘costs’ had been considered over the 12 month period:
INBCM = SAVINGCM − COST INT
The cost of implementing each intervention (COSTINT) was  spec-
iﬁed as one of four different values taken from across a plausible
spectrum ranging from a ‘low cost’ scenario (£250/12 months) to
a ‘high cost’ scenario (£1000/12 months). Due to the huge inter-
farm variation in the cost of implementing mastitis interventions,
any speciﬁed range could be considered to be arbitrary. Therefore,
rather than trying to predict the actual cost of implementing spe-
ciﬁc interventions, a range of values was speciﬁed to provide an
indication as to how much ‘room for investment’ there was for
each speciﬁc intervention. The actual cost of implementation can be
entered in the decision support tool in order to make farm-speciﬁc
predictions.
Parameters throughout the model were estimated from 10,000
Markov chain Monte Carlo (MCMC) iterations, following a burn-
in of 1000 simulations. Three chains starting at ‘overdispersed’
initial values were simulated and convergence was assessed by
comparing intra- and inter-chain variability using the Brooks-
Gelman-Rubin diagnostic (Brooks and Gelman, 1998; Gelman and
Rubin, 1992).
An indicator variable was  set to 1 at each intervention when the
micro-simulation model predicted an INB of £1000 or greater and
otherwise to 0. The mean value of this indicator over the 10,000 iter-
ations provided an estimate of the probability of exceeding a return
of £1000. Predictions of INB were plotted for each of the four dif-
ferent values of COSTINT to produce probabilistic cost-effectiveness
curves that display the probability of saving, at least, £1000 over 12
months at different levels of mastitis for each intervention (Fig. 2).
A cut point probability of ≥60% for a saving ≥£1000 in a 12 month
period was  used to label interventions as potentially cost-effective;
these interventions are reported. A saving of £1000 in a 12 month
period was  considered by the authors to be a worthwhile saving
for demonstration purposes but farmers will be able to stipulate
their own  desired level of saving in the decision support tool. An
alternative approach would have been to simply provide the result-
ing posterior distribution for the INB, however, by selecting the
threshold of £1000, we  were able to demonstrate how the poste-
rior distribution can be used to provide intuitive predictions for
clinical decision makers.
2.4. Somatic cell count micro-simulation model
The micro-simulation steps took the same form for the somatic
cell count micro-simulation model except the cost of a case of
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Fig. 3. Scatterplot of observed and predicted values of the percentage change in the incidence rate of clinical mastitis in the ﬁrst 30 days after calving (IRCM30) in the 12
months  since the mastitis control plan was  instigated.
HighSCC was deﬁned by the normal distribution; COSTSCC ∼ Normal
(mean = 290, sd = 112) (Green et al., 2009).
3. Results
3.1. Herd parameters
The median size of the 77 herds selected for analysis was
187 cows (range 51–553) and the median 305d milk yield
was 8611 kg (range 4297–10590). The median incidence rate of
CM in the 12 months prior to mastitis interventions was  59.5
cases/100 cows/year (range 18–164) and the median 12-month
average BMSCC was 206,000 cells/ml (range 74,000–398,000).
The median IRCM30 at the time of the initial herd visit was 13
cases/100 cows/month (12-month average, range 0.25–36.25) and
the median HighSCC rate was 18.35%/month (12-month average,
range 1.9–43.8).
3.2. Interventions
A total of 112 interventions were evaluated in the analysis
and the number of farms implementing each of the interven-
tions ranged from 2 to 15. Interventions that were found to be
cost-effective in most scenarios were reported resulting in 13 inter-
ventions for the CM model and 9 interventions for the SCC model.
The reported interventions could be broadly grouped into three cat-
egories; management of the dry cow environment, management of
the calving cow environment and the selection and application of
dry cow therapy (Tables 1 and 2).
3.3. Micro-simulation models
3.3.1. Regression model ﬁt
Both regression models demonstrated a good ability to predict
the incidence rate of IRCM30 and HighSCC for a given farm, with
the model predictions explaining over 84% of the variability in the
observed data in the clinical mastitis regression model (Fig. 3) and
78% in the somatic cell count regression model (Fig. 4).
3.3.2. Cost-effectiveness outcome
The probability of an incremental net beneﬁt of at least £1000 for
different interventions is provided in Tables 1 and 2 and Fig. 2. Inter-
ventions in the clinical mastitis micro-simulation model that were
cost-effective for most farms (>75% probability of saving £1000
with initial IRCM30 of 2 cases/12 cows and a COSTINT of £500) were
dry cow rations being formulated by a suitably qualiﬁed nutrition-
ist as opposed to an unqualiﬁed person, selecting dry cow therapy
(DCT) at cow level (selective) rather than at herd level (blanket),
balancing calcium and magnesium in the dry cow rations, designing
cubicles in such a way that 90% of dry cows lied in them cor-
rectly and not drying-off cows during foot trimming procedures.
The interventions in the somatic cell count micro-simulation model
that were cost-effective for most farms (>75% probability of saving
£1000 with initial HighSCC rate of 20% and a COSTINT of £500) were
spreading bedding evenly in dry cow yards as opposed to poor bed-
ding spreading, abrupt drying off as opposed to once daily milking
and calving in individual pens as opposed to communal yards.
Interventions in the clinical mastitis micro-simulation model
that were sensitive to the cost of the intervention and the initial
IRCM30 and therefore only likely to be cost-effective in certain
scenarios included cleaning dry cow cubicles at least twice daily,
calving in individual calving pens as opposed to communal yards,
milking cows for the ﬁrst time within 24 h of calving and consider-
ing both antibiotic and non-antibiotic dry cow therapy approaches
for low somatic cell count cows. Interventions in the somatic cell
count micro-simulation model that were sensitive to the cost of the
intervention and the initial HighSCC rate included milking cows for
the ﬁrst time within 24 h of calving, removing calves from the cow
within 24 h of birth and differentiating infected from uninfected
cows at drying off using SCC records from the current lactation.
4. Discussion
This study illustrates how the clinical efﬁcacy of speciﬁc masti-
tis interventions can be quantiﬁed and incorporated into a Bayesian
cost-effectiveness model using a one-stage micro-simulation. This
is the ﬁrst intervention study to explore the cost-effectiveness of
mastitis interventions within a Bayesian framework, the results of
which are to be incorporated into a decision support tool that will be
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Fig. 4. Scatterplot of the observed and predicted values of the percentage change in the monthly percentage of cows that had a somatic cell count <200,000 cells/ml at the
milk  recording prior to drying off, that were >200,000 cells/ml at the ﬁrst milk recording after parturition (HighSCC) in the 12 months since the mastitis control plan was
instigated.
Table 1
Probability of saving at least £1000 after 12 months at different incidence rates of clinical mastitis in the ﬁrst 30 days after calving (IRCM30) and for different costs of
implementing the intervention. Interventions ranked from most cost-effective to least.
Cost of Intervention (£)
Intervention IRCM30 (cases/12 cows) 250 500 750 1000
Dry cow rations should be formulated by a
suitably qualiﬁed nutritional advisor
1.5 0.92 0.89 0.85 0.80
2.0  0.95 0.94 0.92 0.89
3.0  0.98 0.97 0.96 0.95
Dry  cow therapy (DCT) should be selected at
the cow level (a suitable product for each cow)
rather than herd level
1.5 0.84 0.76 0.67 0.57
2.0  0.92 0.88 0.83 0.77
3.0  0.97 0.96 0.93 0.91
Calcium and magnesium should be balanced to
prevent milk fever
1.5 0.77 0.71 0.65 0.58
2.0  0.85 0.81 0.77 0.71
3.0  0.90 0.88 0.86 0.84
Cows  must not be dried off during
foot-trimming
1.5 0.76 0.70 0.63 0.56
2.0  0.83 0.79 0.75 0.70
3.0  0.89 0.87 0.85 0.82
Cubicles should be designed such that at least
90% of dry cows will lie in them correctly at all
times
1.5 0.74 0.67 0.60 0.54
2.0  0.82 0.78 0.73 0.68
3.0  0.88 0.86 0.84 0.81
Dung,  soiling and wet bedding should be
removed at least twice daily from dry cow
cubicles
1.5 0.70 0.59 0.48 0.38
2.0  0.83 0.76 0.68 0.60
3.0  0.92 0.89 0.85 0.80
Cows  should be milked for the ﬁrst time within
24  h of calving
1.5 0.70 0.60 0.50 0.40
2.0  0.81 0.75 0.68 0.60
3.0  0.90 0.87 0.83 0.79
Cows  should calve in individual pens rather
than communal yards
1.5 0.65 0.56 0.47 0.39
2.0  0.76 0.70 0.63 0.56
3.0  0.86 0.82 0.78 0.74
Both  antibiotic and non-antibiotic DCT
approaches should be considered for low
somatic cell count cows
1.5 0.50 0.39 0.29 0.21
2.0  0.65 0.56 0.47 0.39
3.0  0.80 0.74 0.68 0.62
Clean  bedding material should be applied to
dry cow cubicles at least once daily if using
organic bedding
1.5 0.46 0.36 0.27 0.20
2.0  0.61 0.52 0.44 0.36
3.0  0.76 0.70 0.64 0.58
Pasture must not be grazed for more than 2
consecutive weeks and must be rested for at
least 4 weeks before cows are returned to graze
1.5 0.41 0.33 0.26 0.20
2.0  0.52 0.45 0.39 0.33
3.0  0.63 0.59 0.54 0.49
Straw  yards for calving cows should be cleaned
out completely at least once per month
1.5 0.40 0.28 0.20 0.13
2.0  0.58 0.47 0.37 0.29
3.0  0.74 0.67 0.60 0.53
Calves  must only be allowed to suckle their
own  dam to prevent the possible transfer of
pathogens in milk between cows
1.5 0.28 0.19 0.12 0.07
2.0  0.44 0.35 0.26 0.19
3.0  0.64 0.56 0.48 0.41
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Table 2
Probability of saving at least £1000 after 12 months at different monthly percentages of cows that had a SCC <200,000 cells/ml at the milk recording prior to drying off,
that  were >200,000 cells/ml at the ﬁrst milk recording after parturition (HighSCC) and different costs of implementing the intervention. Interventions ranked from most
cost-effective to least.
Cost of Intervention (£)
Intervention HighSCC% 250 500 750 1000
Cows should calve in individual pens rather
than yards rather than communal yards
15 0.84 0.78 0.72 0.65
20  0.90 0.86 0.83 0.78
30  0.95 0.93 0.91 0.89
Drying off must be abrupt; that is, cows should
not be milked once daily in the days prior to
drying-off
15 0.84 0.78 0.72 0.65
20  0.90 0.86 0.83 0.78
30  0.95 0.93 0.91 0.89
Bedding should be spread evenly rather than
unevenly in straw yards for dry cows
15 0.80 0.76 0.71 0.66
20  0.86 0.83 0.79 0.76
30  0.90 0.89 0.87 0.85
There  must be good ventilation but without
draughts in all calving cow housing
15 0.64 0.56 0.48 0.41
20  0.73 0.67 0.61 0.55
30  0.82 0.79 0.75 0.71
The  calf should be removed from the cow
within 24 h of birth after ensuring colostrum
has been fed
15 0.62 0.53 0.44 0.36
20  0.74 0.66 0.60 0.52
30  0.84 0.80 0.76 0.72
Cows  should be milked for the ﬁrst time within
24 h of calving
15 0.59 0.49 0.40 0.32
20  0.72 0.64 0.56 0.48
30  0.83 0.79 0.74 0.69
Dry  cow therapy must be administered hygienically, as detailed in the
standard operating procedure provided with the training materials
15 0.52 0.43 0.34 0.26
20  0.65 0.57 0.49 0.42
30  0.78 0.73 0.68 0.63
You  should differentiate infected from uninfected cows
using somatic cell count records from the current lactation
15 0.42 0.34 0.27 0.21
20  0.54 0.47 0.40 0.34
30  0.66 0.61 0.56 0.51
Each  quarter should be stripped within 4 h of calving to
check for mastitis
15 0.38 0.29 0.22 0.16
20  0.52 0.44 0.36 0.29
30  0.68 0.62 0.55 0.49
made available to veterinarians/advisors involved with implement-
ing the AHDB Dairy Mastitis Control Plan in the United Kingdom.
Interventions relating to the design and comfort of dry cow cubi-
cles such as designing cubicles in such a way that cows lie in them
correctly and removing dung and wet bedding from cubicles at
least twice daily were potentially cost-effective interventions in
the clinical mastitis micro-simulation, and aspects of management
related to these have been highlighted previously (Barkema et al.,
1999). This earlier study identiﬁed the type of cubicle divider and
thickness of cubicle bedding to be associated with the incidence
rate of clinical mastitis. The hygiene of dry cow cubicles has been
associated with changes in bulk milk somatic cell count (Barkema
et al., 1998) and clinical mastitis incidence rate (Schukken et al.,
1991; Green et al., 2007b), and this highlights the need to provide
comfortable, clean cubicles for dry cows as well as lactating cows.
Another aspect of the dry cow environment which is impor-
tant but commonly overlooked is the grazing management and
speciﬁcally the rotation of paddocks. In this study a ‘graze 2, rest
4’ policy was used (paddocks are grazed for no more than 2 con-
secutive weeks and then rested for no less than 4 weeks), and
whilst the effect of this intervention was relatively small in each
of the micro-simulation models, the combined predicted reduc-
tion in clinical mastitis and somatic cell count would make this an
intervention likely to be cost-effective, providing the cost to imple-
ment it was modest. This is in agreement with two previous studies
that found this intervention to be associated with reduced somatic
cell counts and clinical mastitis incidence in UK dairy herds (Green
et al., 2007b, 2008), and emphasises the need to consider pasture
contamination and ways to mitigate these risks.
The use of individual calving pens, as opposed to communal
yards, had a high probability of cost-effectiveness, and this has been
identiﬁed as an important risk factor by previous studies (Hutton
et al., 1991; Bartlett et al., 1992; Barkema et al., 1998; Barnouin
et al., 2004; O’Reilly et al., 2006). This effect may  be due to a
reduction in pathogen exposure but may  also reﬂect indirectly, the
negative impact of cross-suckling calves which has been associated
with clinical mastitis incidence in the current study and previously
(Green et al., 2007a). Cross-suckling would also be less likely to
occur when calves are removed within 24 h of calving and this
intervention was  associated with a moderate probability of a £1000
return in the somatic cell count micro-simulation model.
Selecting dry cow therapy at cow level was  associated with a
reduced IRCM30, as has been reported previously (Green et al.,
2007b). Since neither the products used nor the criteria applied to
select between cows was speciﬁed in this study, it remains unclear
whether some approaches to selective dry cow therapy are superior
to others.
Having a policy of using both antibiotic and non-antibiotic
approaches when drying-off low somatic cell count cows was  pre-
dicted to reduce IRCM30 and was  very likely to be a cost-effective
intervention. Importantly, such a policy will also reduce the quan-
tity of antimicrobial usage on farm. With the increasing concerns
about antibiotic resistance comes an increasing pressure on dairy
farmers to reduce antibiotic usage (Call et al., 2008; Oliver et al.,
2011). In herds such as these with a low prevalence of contagious
mastitis and a relatively low bulk milk somatic cell count, the tar-
geting of antibiotic dry cow therapy at cows infected at drying
off and use of non-antibiotic teat-sealants in uninfected cows is
a rational and effective approach to dry cow therapy (Huxley et al.,
2002; Green et al., 2008; Bradley et al., 2010; Cameron et al., 2015).
Irrespective of which dry cow therapy products are used at drying-
off, interventions affecting the hygiene of the procedure itself, and
the cleanliness of the environment in which it is performed, were
shown to be potentially cost-effective in both models and conﬁrms
previous study ﬁndings (Peeler et al., 2000; Barnouin et al., 2004,
2005; Green et al., 2008).
Two interventions in the clinical mastitis micro-simulation
model that were predicted to be highly cost-effective in most
scenarios were the formulation of dry cow rations by a suitably
qualiﬁed nutritional adviser and the balancing of calcium and
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magnesium to prevent milk fever. This is also in agreement with
other studies investigating the role of nutrition in mastitis control
(Kremer et al., 1993; Oltenacu and Ekesbo, 1994; O’Rourke, 2009).
These studies reported that mastitis was more likely to occur in
cows diagnosed with clinical ketosis and cows deﬁcient in vita-
mins and trace elements such as selenium, vitamin E, copper, zinc,
vitamin A and -carotene.
The uncertainty in clinical and ﬁnancial outcome for an indi-
vidual farm is important, and illustrates the usefulness of using a
probability distribution for anticipated ﬁnancial returns. The inte-
grated Bayesian model used in this analysis simultaneously derived
the joint posterior distribution for all unknown parameters and
propagated the effects through the predictive cost-effectiveness
model. In this example, uncertainty in the cost of mastitis for
each herd is included as well as the uncertainty of the effects of
the interventions. There are several advantages of this approach,
which have been outlined previously (Spiegelhalter and Best, 2003;
Spiegelhalter et al., 2004). The main disadvantages of the uniﬁed
Bayesian approach include the need for full MCMC  software in order
to obtain a solution although this is currently freely available (Lunn
et al., 2000) and it can also be difﬁcult to evaluate or check model
accuracy (Green et al., 2010). Such uniﬁed Bayesian models are
used widely in human medicine (Parmigiani, 2002; Spiegelhalter
et al., 2004), but there are few examples in the veterinary litera-
ture (Green et al., 2010; Archer et al., 2014). They provide a useful
method to improve the understanding of the uncertainties involved
in clinical decision making and therefore have much to offer the
decision analyst and decision-maker (Cooper et al., 2004).
The results of this research were incorporated into a
spreadsheet-based decision support tool to enable vets and farm-
ers to explore different scenarios applicable to them. Farm-speciﬁc
parameters can be entered and required savings speciﬁed, resulting
in predictions that are relevant to each individual farm. Informa-
tion regarding the herd size, current clinical and subclinical mastitis
performance and costs can be inputted in addition to the cost of
implementing each intervention. The level of saving required after
12 months is then speciﬁed according to the farmers needs and
the decision support tool calculates the probability of making the
speciﬁed level of return and displays this as a probability distribu-
tion so the uncertainty can be visualised. The decision support tool
also allows different combinations of interventions to be evaluated
simultaneously so that many different scenarios can be explored.
This research measured the cost-effectiveness of mastitis inter-
ventions in herds speciﬁcally with an ‘EDP’ diagnosis and as such
it is difﬁcult to know how these ﬁndings would translate to herds
more generally. The results may  have been inﬂuenced by participa-
tion bias due to characteristics common to the plan deliverers that
submitted data compared with those that didn’t. It is also likely that
the results are biased towards herds seeking veterinary input with
respect to mastitis control rather than being representative of the
national herd as a whole. However, the data most likely provides a
true reﬂection of dairy herds seeking veterinary input with respect
to mastitis control and is, therefore, of value to those involved in
the delivery of these services.
5. Conclusions
In this study, data from 77 UK dairy herds were used to explore
the cost-effectiveness of speciﬁc mastitis control interventions in
herds with a particular problem with IMI  acquired during the dry
period. Results from the Bayesian micro-simulation models iden-
tiﬁed that a variety of interventions would be cost effective in
different farm circumstances. The cost-effectiveness of different
interventions has been incorporated in a decision support tool to
assist optimal decision making by veterinary practitioners in the
ﬁeld.
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